Jatropha seeds have gained popularity as a biodiesel fuel resource. The process of biodiesel production from the seeds, however, also creates a tremendous amount of defatted residue as a byproduct. In this study, the potential for pharmaceutical usage of extracts from the defatted residue of crushed Jatropha curcus L. seed was examined. Organic and water fractions of both ethyl acetate (EtOAc) and methanol (MeOH) extracts from the seed residue exhibited an inhibitory growth effect on the human cancer cell lines hepatocellular carcinoma (HuH-7) and breast cancer (MCF-7). Later, the effect of isoamericanol A from the MeOH-organic fraction was compared across three human cell lines in search of human cell types suitable for treatment (HuH-7, MCF-7, cervical cancer (HeLa)). Our results indicate that the effect of three-day isoamericanol A treatment differs by cell type. Although effective to some extent, HeLa cell growth was most inhibited at the smallest dosage, whereas MCF-7 growth suffered the greatest inhibition at the highest dosage. Our findings reveal possibility for utilization of the Jatropha seed residue extract as well as its active compound, isoamericanol A, as practical cancer treatments for certain cell types in the future.
Jatropha (Jatropha curcus L., Euphorbiaceae) is a shrub found throughout the tropical and subtropical regions of Latin America, Africa and Asia [1] . Because its seed kernels possess 40-60% oil, Jatropha seeds have been utilized for biodiesel production [2; 3] . In the process of fuel production, however, it yields a great amount of defatted residue as a byproduct. Uses for many parts of the Jatropha tree are well-known; the roots for their detoxification capacity [4] , the root bark for its antiproliferative activity on human liver cancer cell line (HepG2) [5] , the latex for its antibacterial activity, and the leaves for their antipyretic and analgesic effects [6] . Interestingly, there are reports that its seeds have conflicting properties; while the diester of 12-deoxyl-16-hydroxyphorbol identified in its seed oil has been considered a tumor promotor [7] , anticancer activity in vitro has been observed by application of the extract obtained from Jatropha's curcin seeds [8] . Jatropha, which possesses its own suppressive mechanism against these tumor promoting properties, contains great potential in its seed residue for antitumor/anticancer treatment. In this study, organic and water fractions of both the EtOAc and MeOH residue extracts were subjected to examination of anticancer capability. We treated human cell lines of hepatocellular carcinoma (HuH-7) and breast cancer (MCF-7) with these four fractions.
In addition to evaluation of the anticancer capacity of the four fractions, treatment of isoamericanol A, a catechol neolignan ( Figure 1 ) identified from the MeOH-organic fraction, was applied to three types of human cell lines (HuH-7, MCF-7, and human cervical cell line (HeLa)) to determine its relative degrees of effectiveness. One possible explanation for these anticancer properties is the high antioxidant content of the defatted Jatropha seed residue. Free radicals favor more stable covalent bonding to macromolecules such as enzymes, proteins, lipids, and DNA in healthy human cells. As all cells are exposed to free radicals, oxidation may be the major cause of carcinogenesis at tumor sites for several forms of cancer [9] . Suzuki et al. examined the total phenolic content (TPC) and antioxidant activity of the four fractions (organic and water fractions of both EtOAc and MeOH) of the defatted Jatropha seed residue, using the Folin-Ciocalteu method and the 1,1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging method, respectively [10] . The MeOH-organic fraction was found to show the highest TPC and antioxidant activity among the fractions. Eight catechol-type compounds (a lignin, five neolignans, and two sesquineolignans) were then isolated from the MeOH-organic fraction and all exhibited high TPC and antioxidant activity [10] . Among the eight compounds, isoamericanol A was selected for further study on inhibitory effect on MCF-7 proliferation [11] . However, the ideal cancer cell target type for isoamericanol A has not yet been identified.
Almost all parts of Jatropha have long been used as traditional folk medicine in tropical and subtropical countries for a variety of sicknesses. Firstly for this study, the defatted seed residue was evaluated for its anticancer properties to determine its potential for effective medicinal utilization. Secondly, the effect of the MeOHorganic constituent isoamericanol A was compared across three human cell lines in search of the most applicable human cells.
The crushed seeds were initially defatted by n-hexane, and the resulting residue was successively extracted with EtOAc and MeOH Figure 2 ). These extracts were further partitioned with EtOAc and water (liquid-liquid distribution) to obtain organic and water fractions of both, which were evaporated to dryness in vacuo.
Figure 2:
The fractionation steps for the crushed Jatropha seeds. Using the Soxhlet extractor, three different solvents were used to extract from the seeds. After defatting by n-hexane extraction, the seeds were extracted successively with EtOAc and MeOH. Those extracts were further partitioned to organic and water fractions by EtOAc and water [liquid-liquid distribution].
The four fractions were tested for anticancer properties by three-day treatment of the human hepatocellular carcinoma cell line, HuH-7 ( Figure 3 -A), and the human breast cancer cell line, MCF-7 ( Figure  3 -B). At first glance, the growth of both HuH-7 and MCF-7 cells was inhibited almost in a dose-dependent manner by treatment of the defatted seed residue. Overall, there was a tendency for greater growth inhibition in HuH-7 cells than in MCF-7. On Day 3, the percent difference in growth reduction between the control treatment and the lowest tested concentration (25 µg/mL), was calculated for both HuH-7 ( Figure 3 -A) and MCF-7 ( Figure 3 -B). By EtOAc-organic treatment, cell growth was inhibited 35.4% (p<0.05) on HuH-7 and 3.48% on MCF-7. For the EtOAc-water fraction treatment, these values were 37.2% (p<0.05) and 2.12%, respectively. MeOH-organic treatment yielded values of 50.9% (p<0.01) and 13.1%, and MeOH-water treatment 30.5% (p<0.05) and 14.8%. As shown, Jatropha seed residue was more effective on HuH-7 cell growth inhibition than MCF-7 at this dosage. In addition to the high TPC and antioxidant activity results, the MeOH-organic fraction exhibited the greatest inhibition of HuH-7 proliferation. Both MeOH extracts exhibited a greater effect on MCF-7 than did the EtOAc extracts.
On Day 3, the percent difference in growth reduction between the control treatment and the highest tested concentration (100 µg/mL), was evidently high for the treatments of all four seed residue fractions in both MCF-7 and HuH-7, demonstrating a strong anticancer characteristics ( Figure 3 ). This implies that the three fractions, which did not exhibit as strong antioxidant activity as the MeOH-organic fraction, may also possess numerous other active constituents pertaining to anticancer activity. Further investigation is important to identify the constituents that exhibit such strong anticancer properties.
Although the seed residue demonstrated a strong cancer cell growth inhibition, as a natural product, each fraction sample would contain different amounts of constituents, resulting in different effects/mechanisms on the growth inhibition throughout trials. Therefore, it is important to further examine the anticancer function of the individual constituents. One of them, isoamericanol A, was synthesized as a racemate, enacting an antiproliferative property through a more stable mechanism. The differences in percent growth inhibition between the control and 25 µg/mL isoamericanol A treatment (the lowest tested concentration) on Day 3 were 22.1%, 35.9% (p<0.001), and 80.2% (p<0.001) for HuH-7 (Figure 4-C) , MCF-7 (Figure 4-D) , and HeLa (Figure 4 -E) cells, respectively. Unlike the case of the seed residue fraction treatments, isoamericanol A showed a greater inhibitive effect on MCF-7 than HuH-7. Evidently, isoamericanol A was significantly most effective on HeLa cells at a low dosage.
In the case of the high highest sample treatment (100 µg/mL) on Day 3, cell proliferation was reduced by 84.6% (p<0.001) in HuH-7 and 83.7% (p<0.001) in MCF-7 compared to the control. This reduction by the MeOH-organic treatment was the highest in both HuH-7 and MCF-7 among the four seed residue fractions. These results are substantiated by the strong growth inhibition exhibited by isoamericanol A treatment on both HuH-7 and MCF-7. However, relative comparisons at the highest isoamericanol A dosage (100 µg/mL) at the end of Day 3 differ; proliferation was inhibited 84.1% (p<0.01), 98.9% (p<0.001), 92.3% (p<0.005) for HuH-7 ( As is evident, isoamericanol A was slightly more effective on MCF-7 at a high dosage than on HeLa. The 100 µg/mL isoamericanol A treatment nearly halted HuH-7 and HeLa growth by Day 3 ( Figure  4 -C and E). However, 100 µg/mL treatment inhibited MCF-7 growth immensely from Day 1 (78.1%; p<0.005) and nearly led the cells to total depletion by Day 3 (Figure 4-D) . Further study is required to assess what quantity of isoamericanol A is most beneficial for inhibiting proliferation of particular cell types.
Observing our results, it seems antiproliferative features of the active MeOH-organic compound isoamericanol A are a result of its high antioxidative properties. The catechol neolignan isoamericanol A is considered one of the main contributors to the antioxidant property of the MeOH-organic fraction [10; 12] . It is possible this structure in isoamericanol A is also the factor responsible for its anticarcinogenicity.
In present clinical use, etoposide, the semisynthetic derivative of the lignin podophyllotoxin, is particularly well-known for small cell lung carcinoma and testicular cancer treatment, in spite of a measure of cytotoxicity towards normal cells [13] . While podophylltoxin shows moderate antioxidative activity [14] , isoamericanol A exhibits strong antioxidative activity. The antiproliferative characteristics of isoamericanol A was exhibited in three different human cell lines (HuH-7, MCF-7, and HeLa cells). Although a level of cytotoxicity is expected to be observed in normal cells, the different inhibition patterns accompanying varying dosages on the cell types tested (Figure 4) indicate a cell-specific function of isoamericanol A that likely has a part in determining the severity of toxicity. Investigating the reason behind this function's specificity is the next step to finding the best future applications for isoamericanol A.
In conclusion, our findings have shown both organic and water fractions of EtOAc and MeOH extracts from defatted Jatropha seed residue to be effective inhibitors of hepatocellular and breast cancer cell growth. Moreover, it is possible that the high TPC and antioxidant activity in the MeOH-organic fraction is due to a structural attribute of one of the constituents [10; 12] , namely isoamericanol A. These properties are be the key to discovering Anticancer properties of Jatropha Curcus seed residue and isoamericanol A Natural Product Communications Vol. 12 (12) 2017 1883 isoamericanol A's applicability as an anticancer treatment. Isoamericanol A did not exhibit inhibition on HuH-7 growth as much as on other human cancer cell lines, though still effected suppression to some degree. HeLa cells were most significantly inhibited by the smallest dosage of isoamericanol A after a treatment period of three days. The growth of MCF-7, on the other hand, was most inhibited by the highest dosage. It is necessary to continue identifying the constituents of Jatropha seed residues and analyzing their unique functions, along with those of isoamericanol A.
Experimental

Reagents and chemicals:
Dimethyl sulfoxide (DMSO) and phenol were purchased from Nakalai Tesque, Inc (Kyoto, Japan). Dulbecco's Modified Eagle Medium (D-MEM) was purchased from Sigma-Aldrich (Tokyo, Japan). Human cancer cell lines HuH-7 and MCF-7 were purchased from JCRB Cell Bank, NIBIOHN (Osaka, Japan). HeLa cells were received as a generous gift from the Department of Perinatology and Gynecology, Faculty of Medicine, Kagawa University. Fetal bovine serum and penicillin-streptomycin for cell culture were purchased by GE Healthcare Life Sciences (Buckinghamshire, UK). Cell Counting Kit-8 (CCK-8) was purchased from Dojindo Molecular Technologies, Inc (Tokyo, Japan).
Plant Materials:
The dried Jatropha seeds were kindly given by Dr. Tanachai Pankasemsuk of the Faculty of Agriculture, Chiang Mai University, Thailand. Jatropha was harvested at the university farms.
Seed extraction and isolation of isoamericanol A:
The Jatropha seeds (101 g) were crushed with a blender. Soxhlet extractions were performed on the crushed seeds by application of three different solvents; n-hexane, EtOAc, and MeOH, in this order. Later, EtOAc/water liquid-liquid distribution was performed to separate the EtOAc and MeOH extracts to organic and water fractions, for a total of four fractions. The EtOAc-organic (1.52 g), EtOAc-water (0.161 g), MeOH-organic (0.794 g), and MeOH-water (3.11 g) fractions were concentrated under reduced pressure. The MeOHorganic was purified by chromatography and isoamericanol A isolated as one of the active compounds [10] .
Sample preparation: Isoamericanol A was synthesized by a radical coupling reaction of caffeyl alcohol with Ag 2 CO 3 [15] . The concentration of four fractions and isoamericanol A used for the assays were 0, 25, 50, and 100 µg/mL. All four different concentrations of the five tested sample mediums were included 1% DMSO. These solutions were filtered with a 0.45 μm filter syringe before administration to the cells.
Determination of anticancer ability:
Cell proliferation ability was observed over a five-day schedule (Day -1, 0, 1, 2, and 3 ). HuH-7 (5000cells/well), MCF-7 (3000-5000cells/well), and HeLa (1000 cells/well) cells were seeded in 50 µL of D-MEM medium including 10% heat-inactivated fetal bovine serum and 1% penicillinstreptomycin on a 96-well plate one day prior to the sample administration (Day -1). The 96-well plate was stored at 37°C under a humidified atmosphere of 5% CO 2 during this five-day experiment. On Day 0, 50 µL of all four dosages at doubled concentration were added to wells containing 50 µL medium, diluting the dosages to their original concentrations. CCK-8 was applied to the cell culture medium for four successive days to examine the inhibition of cancer cell growth by the four fractions and isoamericanol A. A colorless WST-8, or water-soluble tetrazolium, yields an orange WST-8 formazan product in the presence of phenazine methosulfate (PMS). The intensity of the product's color is a direct indicator of the number of cells in phosphate-buffered saline. The absorbance of formazen in cells by different sample treatments was measured with an ultraviolet-visible spectrophotometer at 450 nm each of four consecutive days (Day 0, 1, 2, and 3) at the same time of day. Cell numbers were calculated by plotting absorbance against cell number seeded on Day 0 using a standard curve. The percent reduction of cell growth was calculated by the following equation: 100 -(N25 or N100/N0) x 100, where N25 or N100 is the number of cells treated by the 25 µg/mL or 100 µg/mL sample treatment on Day 3, and N0 is the number of cells treated by the 0 µg/mL sample treatment on Day 3.
Statistical analysis:
Data are expressed as mean ± standard error (SE) from three independent trials. The significance of difference between the control and sample-treated groups was evaluated by ANOVA and/or Student's t-test, using GraphPad Prism (Graph Pad Software, Inc., USA). Statistical significance was set at p<0.05.
